Testimony and Comments
Do No Harm Calls on CMS to Withdraw Proposed Rule that Encourages Racial Prioritization for Kidney Transplants
Share:
On June 12, 2024, Do No Harm Board Chairman Dr. Stanley Goldfarb submitted a comment on the Centers for Medicare and Medicaid Services’ (CMS) recently-proposed rule regarding the Increasing Organ Transplant Access (IOTA) Model, which will incentivize hospitals to create so-called “health equity” goals to reduce disparities in treatment for end-stage renal disease. If the rule takes effect, providers will almost certainly and intentionally select patients for kidney transplantation based on race. A more sensible solution—one focused on patient education—is possible and advisable.
In an effort to prevent CMS from encouraging such race-based practices with regards to kidney transplants, Dr. Goldfarb and Do No Harm are calling on CMS to withdraw its proposed rule.
Read the full comment below:
